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OBJECTIVES The aim of the study was to evaluate the effectiveness of cardiac resynchronization therapy
(CRT) in patients with refractory heart failure (HF) and incomplete left bundle branch block
(“narrow” QRS), together with echocardiographic evidence of interventricular and intraven-
tricular asynchrony.
BACKGROUND Cardiac resynchronization therapy has been proven effective in patients with HF and wide
QRS by ameliorating contraction asynchrony.
METHODS Fifty-two patients with severe HF received biventricular pacing. The patients were eligible in
the presence of echocardiographic evidence of interventricular and intraventricular asyn-
chrony, regardless of QRS duration. The patient population was divided into group 1 (n 
38), with a QRS duration 120 ms, and group 2 (n  14), with a QRS duration 120 ms.
RESULTS The baseline parameters considered in the study were similar in both groups. At follow-up,
CRT determined narrowing of the QRS interval in the entire population and in group 1 (p
 0.001), whereas a small increase in QRS duration was observed in group 2 (p  NS); in
all patients and within groups, we observed improvement of New York Heart Association
functional class (p  0.001 in all), left ventricular ejection fraction (p  0.001 in all), left
ventricular end-diastolic and end-systolic diameter (p  0.05 within groups), mitral
regurgitation area (p 0.001 in all), interventricular delay (p 0.001 in all), and deceleration
time (group 1: p  0.001, group 2: p  0.05), with no significant difference between groups.
The 6-min walking test improved in both groups (group 1: p  0.001; group 2: p  0.01).
CONCLUSIONS Cardiac resynchronization therapy determined clinical and functional benefit that was similar
in patients with wide or “narrow” QRS. Cardiac resynchronization therapy may be helpful in
patients with echocardiographic evidence of interventricular and intraventricular asynchrony
and incomplete left bundle branch block. (J Am Coll Cardiol 2003;42:2117–24) © 2003 by
the American College of Cardiology Foundation
Despite major therapeutic advances with angiotensin-
converting enzyme (ACE) inhibitors, beta-blockers, and
spironolactone, the prognosis of patients with heart failure
(HF) is substantially poor and disappointing. Additionally,
the previous uncontrolled (1,2) and subsequent randomized
(3–5) trials suggested that cardiac resynchronization therapy
(CRT) determines a clinical and functional benefit by
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reducing ventricular asynchrony. To date, CRT has been a
valid option for patients with dilated cardiomyopathy
(DCM) in New York Heart Association (NYHA) func-
tional class III to IV, together with severe ejection fraction
(EF) depression and prolonged QRS duration (120 to 150
ms) on surface electrocardiogram (ECG).
The rationale for CRT is based on the assumption that
the structural modifications of DCM are responsible for the
development of cardiac asynchrony at various levels (atrio-
ventricular [AV], interventricular and intraventricular), thus
resulting in an abnormal coordination of contraction (6) and
relaxation (7) and in poor hemodynamics, and that these
pathophysiologic deteriorations may be corrected by CRT
(8). Cardiac asynchrony is usually associated with the
presence of an intraventricular conduction delay (i.e., left
bundle branch block [LBBB]), and, for this reason, CRT
has been proposed for patients with a relatively marked
prolongation of the QRS interval on surface ECG. Indeed,
this electrocardiographic aspect is a rather “coarse” and
indirect index of asynchrony. A wide QRS may be helpful in
identifying the presence of interventricular asynchrony (9),
but it may not be related to intraventricular asynchrony or
regional dyssynchronies and, therefore, should not be con-
sidered a specific marker of mechanical asynchrony.
These uncertainties have represented a major limitation
in identifying the “ideal” QRS interval for the selection of
candidates for CRT therapy, ranging from 120 ms (5) to
150 ms and beyond (3).
Our working hypothesis is based on the presence of
contraction asynchrony patterns in patients with DCM and
an incomplete LBBB (“narrow QRS”), even though this
finding is not as frequent as in subjects with complete
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LBBB. Provided that asynchrony is documented, CRT may
be effective in this particular subset of patients.
To validate our hypothesis, a patient population with
severe HF and echocardiographic evidence of interventric-
ular and intraventricular asynchrony was treated by CRT
regardless of the QRS interval on the baseline surface ECG.
METHODS
Patient selection. Between February 2000 and March 2002,
we prospectively evaluated 52 consecutive patients with an EF
35% and with echocardiographic evidence of interventricular
and intraventricular asynchrony (see Echocardiographic sec-
tion) who underwent biventricular pacemaker (PM) implanta-
tion. Our patient population was affected by chronic HF, in
NYHA functional class III to IV, secondary to DCM of any
etiology and refractory to optimal and maximally tolerated
medical therapy (i.e., diuretics, ACE inhibitors, beta-blockers,
and digoxin). All patients had to be in clinically stable condi-
tion at least 30 days preceding the enrollment. The patients
had either a normal sinus rhythm (SR) or had a PM-induced
rhythm. The patients with a prior PM implantation underwent
the procedure for advanced or complete heart block and were
totally PM-dependent. Clinical evaluation and serial echocar-
diographic examinations were carried out throughout the
follow-up (at least six months). Exclusion criteria were perma-
nent atrial fibrillation, inability to perform a technically accept-
able echocardiogram, surgically correctable significant valvular
disease, restrictive or hypertrophic cardiomyopathy, suspected
acute myocarditis, acute coronary syndrome (3 months) or
correctable by revascularization, severe chronic obstructive
pulmonary disease, and inability to walk.
All patients gave their written informed consent before
study enrollment.
Echocardiography. The echocardiographic examination
was performed with a commercially available imaging sys-
tem (Hewlett Padkard Sonos 5500, Hewlett Packard Co.,
Andover, Massachusetts) equipped with an S4 multifre-
quency transducer. The recordings were always performed
by the same physicians (S.F. and D.P.) who were unaware
of the clinical status of the patients at the time of exami-
nation and reviewed in blind. The examinations were
obtained from the parasternal and apical windows with the
patient in the left lateral position. Complete M-mode,
two-dimensional, pulse, continuous wave, and color-
Doppler recordings were performed. M-mode echocardiog-
raphy measurements were made according to the guidelines
of the American Society of Echocardiography (10). Mea-
surements of all indexes were carried out on a minimum of
five consecutive cardiac cycles, and the average value was
used in the analysis. The following parameters were evalu-
ated: left ventricular end-diastolic diameter (LVEDD); left
ventricular end-systolic diameter (LVESD); EF, assessed
using the modified biplane Simpson’s rule (11); severity of
mitral regurgitation (MR), evaluated by measuring the
maximum MR jet area by color-Doppler from the apical
view; left ventricular electromechanical delay, as the time
from QRS onset to systolic aortic flow onset; right ventric-
ular electromechanical delay, as the time from QRS onset to
systolic pulmonary flow onset; interventricular delay (IVD),
as the difference between right and left ventricular electro-
mechanical delay; QRS onset-beginning of transmitral fill-
ing interval (Q-E); posterolateral left ventricular wall acti-
vation delay (Q-LW), from QRS onset to the maximal left
ventricular posterolateral wall inward movement, recorded
from the apical four-chamber view with the M-mode cursor
positioned 1 cm below the mitral annulus on the lateral wall
of the left ventricle; deceleration time (DT) obtained by
extrapolating the time of the decay of the E-wave velocity to
baseline; left ventricular filling time (E-A), as the time from
the beginning to the end of diastolic mitral flow.
Evaluation of asynchrony. The patients were considered
eligible for CRT if interventricular and intraventricular
asynchrony was echocardiographically documented. Inter-
ventricular asynchrony was defined as IVD 20 ms,
whereas intraventricular asynchrony was identified when
Q-LW Q-E and Q-LW 9.9 corrected units (c. u. 
measured interval in ms/ R-R interval); this value represents
the upper 95th percentile of normal values in healthy subjects
(Appendix).
Assessment of functional capacity. The 6-min walking
test (6MWT) was carried out according to the recommen-
dations of Guyatt et al. (12) and Lipkin et al. (13). Patients
used their usual aids and received standardized encourage-
ment at regular intervals. Each visit included two tests
performed after a time lapse of at least 3 h. The recorded
value was the mean of the results of the two tests.
Biventricular pacing system. A permanent left ventricular-
based PM, along with three pacing leads, was implanted in
all patients. The left ventricular pacing lead (Guidant
Abbreviations and Acronyms
ACE  angiotensin-converting enzyme
AV  atrioventricular
CRT  cardiac resynchronization therapy
DCM  dilated cardiomyopathy
DT  deceleration time
E-A  left ventricular filling time
ECG  electrocardiogram
EF  ejection fraction
HF  heart failure
IVD  interventricular delay
LBBB  left bundle branch block
LVEDD left ventricular end-diastolic diameter
LVESD  left ventricular end-systolic diameter
MR  mitral regurgitation
NYHA  New York Heart Association
PM  pacemaker
SR  sinus rhythm
Q-E  Q-wave–transmitral filling E-wave interval
Q-LW  posterolateral left ventricular wall activation
delay
6MWT  6-min walking test
2118 Achilli et al. JACC Vol. 42, No. 12, 2003
Cardiac Resynchronization and “Narrow” QRS December 17, 2003:2117–24
Model 4512, Easy/trak over the wire [Guidant Inc., St.
Paul, Minnesota], or Medtronic Model 2187 or 4191
[Medtronic Inc., Minneapolis, Minnesota]) was advanced
transvenously into a tributary vein of the coronary sinus in
49 patients. Only when this transvenous technique resulted
in failure (three patients) was the pacing lead (Medtronic
Model 4965) positioned epicardially by a small thoracot-
omy. The target pacing position for the left ventricle was the
midportion of the left free wall, which was reached in 49
patients; in 2 patients, the lead was positioned toward the
anterior wall, and, in the remaining 1 patient, the lead was
placed in a basal position.
Optimiziation of the AV delay. Atrioventricular delay
optimization was performed using Doppler echocardiogra-
phy, interrogating transmitral flow with the sample volume
at the tip of the mitral valve leaflets to obtain the best flow
profile. First, the device was programmed to DDD mode
with a lower rate of 40 beats/min to ensure the patient’s
intrinsic rhythm. Subsequently, the sensed AV delay was
programmed to 200 ms. In this setting, mitral valve closure
is delayed to the end of the A wave. The sensed AV interval
was decreased in steps of 20 ms until the mitral valve
Doppler signal caused truncation of the A wave. Finally, the
sensed AV interval was increased in steps of 10 ms to ensure
that the mitral valve closure Doppler signal was synchronous
with, or occurred shortly after, the end of the A-wave; AV
optimization was performed at every follow-up visit.
Data collection. Clinical status, echocardiographic data,
6MWT, and surface ECG were prospectively evaluated in all
patients at baseline, within the week preceding device implan-
tation, before hospital discharge (day 4), after one, three, and
six months, and then every six months. Standard 12-lead
ECGs were recorded at a paper speed of 50 mm/s and a scale
of 10 mm/mV on a Model Landscape instrument (Mortara
Instruments Inc., Milwaukee, Wisconsin). Computed values
of PR, RR interval, and QRS duration were recorded. The
QRS width was evaluated as the mean of two values deter-
mined by automatic analysis of two successive ECGs. A
control of the pacing system and of effective biventricular
capture was also performed during each visit.
The mean follow-up duration was 546  277 days, while
clinical and echocardiographic data were collected after 6
months of follow-up for all patients.
The investigators involved in the clinical follow-up visits,
in echocardiographic examinations, and in the outcome
analysis were unaware of each other’s findings.
Statistical analysis. All statistical analyses were performed
using a software program (SPSS for Windows, version 11.0,
SPSS Inc., Chicago, Illinois). To initially evaluate the net
effect or interference of CRT on every single parameter
considered in the study, we performed an analysis on the
entire patient population (follow-up vs. baseline). More-
over, the net effect of QRS duration was evaluated with a
data analysis within (follow-up vs. baseline) and between
the groups at baseline and after CRT. Summary data are
expressed as mean  SD or percentage of patients. Differ-
ences in quantitative variables in all patients and in each
group were validated using a single or a two-way repeated
measure of variance, as appropriate. Differences in propor-
tions were compared by a chi-square analysis or Fisher exact
test, as appropriate. Linear regression analysis was per-
formed to show the relationship between echocardiographic
and mechanical indexes of synchrony, using QRS duration
as a categorical variable, and differences between regression
lines were performed using analysis of covariance. Bonfer-
roni correction for multiple tests was used for post-hoc
comparisons. A threshold value of p 0.05 was considered
significant.
RESULTS
Patient characteristics. Table 1 illustrates the baseline data
of our patient population. Mean age was 69.6 9 years, and
HF was ischemic in 21 (40%) patients and idiopathic in 31
(60%) patients. Our population was divided into two groups
on the basis of the QRS interval at the time of enrollment:
group 1, consisting of 38 patients with a QRS duration
120 (range 128 to 227 ms), and group 2, consisting of 14
patients with a QRS 120 ms (range 80 to 120 ms). The
only baseline difference between the groups was QRS
duration (p  0.0001).
Clinical and electrocardiographic outcome. The main
features are depicted in Table 2. The only baseline differ-
ence between the two groups was the QRS duration, which
was obviously significantly higher in group 1. After CRT,
QRS duration decreased significantly in the entire popula-
tion and in group 1, whereas a small increase in QRS
duration was observed in group 2. Cardiac resynchroniza-
tion therapy was effective in reducing NYHA functional
class and 6MWT duration in all patients and within the
groups. The improvement in the 6MWT was significantly
greater in group 1 than in group 2 (138.2  68.9 m vs. 93.6
 65.7 m, p  0.01). A total of 10 deaths (19.2%) occurred
during the follow-up: 7 (18.4%) in group 1 (4 sudden
deaths, 2 due to progressive HF, and 1 noncardiac death),
and 3 (21.4%) in group 2 (1 sudden death, 2 due to
progressive HF), with no difference between the groups.
Echocardiographic outcome. Data are summarized in Ta-
ble 3. The baseline characteristics were similar in the two
groups. The EF, LVEDD, LVESD, and MR improved
significantly in all patients after CRT and, to a similar
extent, in both groups. As regards diastole, the E-A interval
did not vary after CRT, whereas DT had increased signif-
icantly at follow-up.
Asynchrony patterns. The baseline interventricular and
intraventricular asynchrony patterns of both groups are
depicted in Figure 1; moreover, in group 1 we analyzed the
patients with (PM) or without (SR) a prior PM implanta-
tion. A comparison between these subgroups did not reveal
any difference regarding IVD (SR: 57.0  32.4 ms, PM:
53.0  24.6 ms; p  0.388), or Q-LW (SR: 416.2  73.9
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ms; PM: 451.7  62.7 ms; p  0.139), or as regards the
other major clinical and functional parameters, therefore
highlighting a substantial homogeneity of the subgroups.
Pacing therapy was effective in the significant reduction
of IVD and Q-LW in the entire patient population. The
QRS duration does not alter the impact of CRT on the
IVD. In fact, IVD significantly improved in all groups after
CRT with no statistically significant difference between the
groups. Moreover, whereas a significant reduction in the
Q-LW interval was observed after CRT only in group 1, the
difference between groups 1 and 2 was not statistically
significant.
A regression analysis of the asynchrony patterns and the
echocardiographic outcome in both groups showed a sig-
nificant inverse correlation between IVD and EF in
group 1 (r2  0.2386; p  0.002) and a direct correlation
between IVD and LVESD in group 1 (r2 0.2229, p
0.003). On the contrary, we did not observe any correlation
betweenQ-LW and the echocardiographic outcome (Fig. 2).
DISCUSSION
The major finding of our paper is that CRT provides a
significant clinical and functional benefit in patients with
incomplete LBBB (QRS 120 ms) and DCM of various
etiologies, selected on the basis of the presence of interven-
tricular and intraventricular asynchrony. This amelioration
is comparable to that obtained in patients who are currently
selected by means of current indications for CRT (QRS
duration 120 to 150 ms) (1–5).
Current study rationale. To date, CRT has been reserved
for patients with refractory HF and a consistent prolonga-
tion of the QRS (120 to 150 ms), as suggested by previous
studies (1–5). This assumption is based on epidemiologic
(14,15), clinical, and experimental data (16–18).
With respect to experimental data, the effectiveness of
CRT is greater in patients with substantial QRS prolonga-
tion (150 ms); this has usually been shown in acute
hemodynamic studies (16,17) and, recently, in the Pacing










Age (yrs) 69.6  9 70.1  9 68.3  8 0.515
Male gender 60% 55% 71% 0.292†
Ischemic DCM 40% 45% 29% 0.353‡
NYHA functional class 3.5  0.5 3.6  0.4 3.4  0.5 0.242
ECG measurements
QRS duration (ms) 152.6  32.1 168.2  21.4 110.0  10.9 0.0001
RR interval (ms) 819.7  127.4 819.1  102.5 821.4  183.6 0.845
PR interval (ms) 158.1  47.7 153.5  47.0 170.7  49.1 0.225
Echo measurements
EF (%) 23.2  4.7 22.6  4.6 24.6  5.0 0.272
LVEDD (mm) 75.9  10.4 77.4  10.6 71.8  9.2 0.077
LVESD (mm) 63.9  9.7 64.8  10.2 61.4  8.4 0.252
MR (cm2) 7.0  4.2 6.9  4.1 7.5  4.7 0.820
6MWT (m) 261.5  85.8 256.0  65.4 276.4  88.9 0.099
Previous pacemaker 11.5% 15.7% 0 0.174‡
Follow-up duration (days) 546  277 565  282 493  264 0.417
*p value based on: analysis of variance, chi-square test, † or Fisher exact test. ‡Data are presented as the mean value  SD, or
percentage of patients.
DCM  dilated cardiomyopathy; ECG  electrocardiogram; EF  left ventricular ejection fraction; LVEDD  left
ventricular end-diastolic diameter; LVESD  left ventricular end-systolic diameter; MR  mitral regurgitation area; NYHA 
New York Heart Association; 6MWT  6-min walking test.
Table 2. Clinical and Electrocardiographic Characteristics Before and After CRT
Characteristics All Patients Group 1 Group 2
1 vs. 2
p Value*
QRS duration baseline (ms) 151.3  30.9 168.2  21.4 110.4  10.9 0.001
QRS duration follow-up (ms) 123.5  9.7‡ 125.2  9.1‡ 120.5  13.1 0.453
NYHA baseline 3.4  0.5 3.5  0.5 3.3  0.5 0.695
NYHA functional class follow-up 1.8  0.5‡ 1.8  0.5‡ 1.7  0.6‡ 1.000
6MWT baseline (m) 258.1  76.3 256.0  65.4 276.4  88.9 1.000
6MWT follow-up (m) 389.8  52.0‡ 394.2  38.4‡ 369.9  70.2§ 0.362
RR interval baseline (ms) 824.8  127.5 819.1  102.5 821.4  183.6 1.000
RR interval follow-up (ms) 800.1  143.2 795.8  149.7 810.7  97.5 1.000
Death (n) 10 (19.2%) 7 (18.4%) 3 (21.4%) 1.000†
*p value based on: analysis of variance or †Fisher exact test; ‡p  0.001 and §p  0.01 vs. baseline. Data are presented as the
mean value  SD or percentage of patients.
CRT  cardiac resynchronization therapy; NYHA  New York Heart Association; 6MWT  6-min walking test.
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Therapies in Congestive Heart Failure II (PATH-CHF II)
trial (18). However, in these studies, patients were consid-
ered eligible in the presence of QRS prolongation on surface
ECG as the only marker of asynchrony, and with no
demonstration of ventricular dyssynchrony using imaging
techniques. Even though the available data in literature
highlights a positive correlation between QRS duration and
interventricular asynchrony (9), the correlation between
QRS duration and intraventricular asynchrony is not
straightforward. Actually, an echocardiographic study on
patients with DCM by Blazek et al. (19) confirmed the
presence of intraventricular asynchrony in 46% and 36% of
patients with LBBB or QRS duration 120 ms, respec-
tively. No correlation was found between the QRS duration
and the degree of mechanical asynchrony. These data are
also confirmed by a more recent observation by Yu et al.
(20), documenting intraventricular systolic asynchrony in
73% of patients with HF and a QRS duration120 ms and
in 51% of patients with a QRS duration 120 ms, respec-
tively. Again, this study did not show any correlation
between QRS duration and systolic asynchrony. Moreover,
Breithard et al. (21) have demonstrated that patients with a
QRS duration 120 ms may show many different patterns
of baseline intraventricular asynchrony, ranging from an
almost complete contraction synchrony between the lateral
wall and the interventricular septum, to a very delayed
lateral wall displacement, and to a paradoxical septal mo-
tion. Søgaard et al. (22) have pointed out that the degree of
intraventricular asynchrony, evaluated with tissue Doppler
imaging, and not the baseline QRS duration, is predictive of
the effectiveness of CRT.
These data stress the concept that, first, interventricular
asynchrony may be perhaps grossly identified by the pres-
ence of a wide QRS (better so if LBBB is present) on
surface ECG (9,17,18), but that, nevertheless, more sophis-
ticated imaging techniques are needed to disclose intraven-
tricular asynchrony; second, that a wide QRS cannot iden-
tify responders to CRT.
Comparison between groups. We are of the opinion that
the strength of our patient selection criteria is supported by
Table 3. Echocardiographic Data Before and After Cardiac Resynchronization Therapy
Characteristics All Patients Group 1 Group 2
1 vs. 2
p Value*
EF baseline (%) 23.0  4.6 22.6  4.6 24.6  5.0 0.591
EF follow-up (%) 33.4  5.1† 33.2  5.4† 33.6  5.9† 1.000
LVEDD baseline (mm) 76.8  10.3 77.4  10.6 71.8  9.2 0.490
LVEDD follow-up (mm) 70.6  10.4† 71.6  10.7‡ 65.6  8.5‡ 0.380
LVESD baseline (mm) 64.7  9.9 64.8  10.2 61.4  8.4 0.839
LVESD follow-up (mm) 57.9  10.3† 57.9  11.0‡ 55.6  8.2‡ 1.000
MR baseline (cm2) 6.9  4.2 6.9  4.1 7.5  4.7 1.000
MR follow-up (cm2) 4.0  3.2† 3.8  2.9† 4.5  3.5† 1.000
IVD baseline (ms) 54.1  29.7 56.4  31.1 42.5  16.6 0.320
IVD follow-up (ms) 14.2  16.9† 15.9  15.2† 6.4  16.8† 0.178
Q-LW baseline (ms) 418.8  71.0 421.8  72.6 395.0  53.9 0.987
Q-LW follow-up (ms) 386.9  55.3‡ 389.7  55.3‡ 363.2  47.3 0.472
E-A baseline (ms) 436.8  124.1 425.3  102.1 471.8  166.3 0.687
E-A follow-up (ms) 455.0  113.7 442.0  120.8 437.5  54.7 1.000
DT baseline (ms) 120.4  29.6 121.5  31.3 117.7  25.8 1.000
DT follow-up (ms) 258.1  76.3† 157.2  29.8† 148.5  17.4‡ 0.223
*p value based on analysis of variance; †p  0.001; ‡p  0.05 vs. baseline. Data are presented as the mean value  SD.
DT  deceleration time; E-A  left ventricular filling time; EF  left ventricular ejection fraction; IVD  interventricular
delay; LVEDD  left ventricular end-diastolic diameter; LVESD  left ventricular end-systolic diameter; MR  mitral
regurgitation area; Q-LW  posterolateral left ventricular wall activation delay.
Figure 1. Baseline duration of QRS (white bars), interventricular delay (black bars), and posterolateral left ventricular wall activation delay (striped bars)
in patients in group 1 with sinus rhythm (SR) at enrollment, with prior pacemaker implantation (PM), and in group 2. The only difference between the
groups is represented by QRS duration (*p  0.001 group 2 vs. RS and vs. PM).
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the evidence of similar baseline characteristics in both
groups with the exception of QRS duration. Moreover, the
effectiveness of CRT on the clinical and functional status of
our patients is similar in the entire population and in both
groups and in agreement with the current data in literature
(1–5,23,24). As a result, EF, NYHA functional class,
LVEDD, LVESD, and MR all improved after CRT
without a substantial difference between the groups. The
6MWT did improve in both groups, but the magnitude of
improvement was higher in group 1 than in group 2. With
respect to diastole, CRT determined a significant increase in
DT in both groups at follow-up, and these data are in
agreement with previous studies (24). This amelioration was
observed in the presence of a constant E-A filling interval
throughout the study, thus indicating a shift from a restric-
tive toward a pseudonormal diastolic pattern. This improve-
ment may contribute to the optimization of global ventric-
ular performance.
When considering the asynchrony indexes, Q-LW indi-
cates the total duration of left ventricular systole, whereas
(Q-LW)  (Q-E) is the expression of the potential overlap
of ventricular contraction and filling (25). We noted a trend
toward the reduction of the Q-LW interval (i.e., intraven-
tricular resynchronization) that was statistically significant
only in group 1. Nonetheless, CRT induced interventricular
resynchronization, as testified to by a significant reduction
of IVD in both groups. Our data are in accordance with
previous studies (26–28) performed with Doppler echocar-
diography that utilized asynchrony measurements similar to
those obtained in our study (26) or tissue Doppler imaging
(27).
Again, we observed an unimpressive, but significant,
inverse correlation between IVD and EF and a direct
correlation between IVD and LVESD only in group 1.
Our study was not specifically conceived to identify the most
powerful outcome predictor after CRT, which has been
identified in recent studies as the pre-pacing intraventricular
delay (21,29), but these observations suggest that the degree
of IVD reduction can predict a favorable outcome in the
long term.
Figure 2. Regression lines (solid line  group 1; dashed line  group 2) show a fairly good correlation between the magnitude of interventricular delay
decrease (IVD) and magnitude of ejection fraction increase (EF) (top) and left ventricular end-systolic diameter decrease (LVESD) (bottom) in group
1 (open squares) but not in group 2 (solid triangles) after cardiac resynchronization therapy.   follow-up  baseline absolute difference. *p value based
on analysis of covariance.
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As regards the correlation between QRS narrowing after
CRT and functional enhancement, acute studies have
clearly shown a lack of correlation between these variables
(30), whereas there is controversial data in literature regard-
ing the correlation between narrowing of the QRS interval
after chronic CRT and clinical improvement (31–33). Even
though chronic CRT usually shortens the QRS interval, in
our series we observed a significant reduction of the QRS
interval in group 1 and an increase in group 2; nevertheless,
the clinical and functional benefit of CRT was present and
significant in both groups, suggesting that the effectiveness
of biventricular pacing may be independent of the evidence
of QRS narrowing. In summary, even though a wide QRS
interval may be associated with the presence of mechanical
asynchrony, it is not to be considered an absolute marker of
this condition, as already underscored by other authors (34).
Study limitations. The major limitation of our study is the
lack of randomization. Nevertheless, our results appear to be
substantiated by the similar baseline characteristics of the
groups and the significant effectiveness of CRT in both
groups, which represent the general population with HF.
Ultimately, the evaluation of intraventricular asynchrony
was obtained with a rather simple and non-sophisticated
M-mode measurement, and a similar method has indeed
been adopted for patient selection in the Cardiac Resyn-
chronization in Heart Failure (CARE-HF) trial (35). Bear-
ing this in mind, we could argue that, if CRT has been
proven to be effective in this patient population that was
selected using such a “simple and reproducible” measure-
ment, we should expect even better clinical outcomes in the
event of patients being selected with more sophisticated
imaging techniques.
Conclusions. Our paper, in agreement with previous stud-
ies (1–5), confirms the effectiveness of CRT in moderate-
severe HF patients refractory to optimal medical therapy.
To our knowledge, it is the first time that such a clinical
benefit has been demonstrated, not only in patients with
major intraventricular conduction delay on surface ECG,
but even in subjects with a QRS interval120 ms, provided
that echocardiographic evidence of interventricular and
intraventricular asynchrony is present. Moreover, this study
stresses the concept that the selection of patients for CRT
should be performed using a mechanical evaluation of left
ventricular contraction, rather than electrical criteria
adopted so far. Further studies on larger patient populations
are obviously needed to confirm our initial results.
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